Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Mckeesport › NPI 1194734798
Hospital

Upmc Mckeesport

Upmc Mckeesport was paid $9.96M by Medicaid between Nov 2019 and Dec 2024, across 218 billing codes. Its largest line is 99284, emergency room visit (serious) — 38% of everything it billed.

33Billing provider infoUPMC MCKEESPORT
MCKEESPORT, PA 15132
33aNPI1194734798assigned 08/05/2006
33bProvider typeSubstance Use Disorder Rehabilitation Hospital Unit
28Total paid$9.96M
24GClaims323,113
24DCodes billed218
24AFirst – last monthNov 2019 – Dec 2024
Compared with peers

Next to other Substance Use Disorder Rehabilitation Hospital Unit providers in Pennsylvania

Rank by total paid#1 of 6
Median peer was paid$744K
This provider vs. median13×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2019563$5K
202029,399$676K
2021120,758$3.32M
202258,680$1.87M
202362,313$2.16M
2024incomplete51,400$1.94M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 38% 21,756 21,075 $3.77M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 15% 13,985 13,631 $1.53M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 13% 6,000 5,807 $1.25M
G0378 Hospital observation service, per hour 5.8% 2,434 937 $581K
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 3.6% 13,626 11,988 $361K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.0% 10,746 10,226 $196K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1.9% 3,242 3,202 $191K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.3% 1,023 1,007 $129K
80053 Comprehensive metabolic panel 1.2% 15,526 14,163 $122K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.2% 31,253 26,226 $119K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1.2% 1,775 1,087 $118K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.2% 2,842 2,701 $117K
206 more codes
70450 Computed tomography, head or brain; without contrast material <1% 1,806 $90K
96375 Therapeutic injection; each additional sequential IV push <1% 6,472 $84K
J9271 Injection, pembrolizumab, 1 mg <1% 130 $82K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 9,729 $63K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 238 $60K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 1,976 $54K
71045 Radiologic examination, chest; single view <1% 8,804 $47K
84484 <1% 6,719 $45K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 691 $43K
80048 Basic metabolic panel (calcium, ionized) <1% 6,801 $37K
71275 Computed tomographic angiography, chest, with contrast material <1% 235 $32K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 212 $32K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 624 $29K
82805 <1% 1,105 $28K
85730 <1% 6,013 $26K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 198 $25K
72125 Computed tomography, cervical spine; without contrast material <1% 442 $25K
80050 General health panel <1% 609 $25K
83735 <1% 5,386 $23K
83605 <1% 4,150 $22K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 352 $22K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,568 $20K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 363 $20K
96367 <1% 1,010 $17K
85610 <1% 7,496 $17K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 505 $17K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 77 $16K
71250 <1% 289 $15K
96417 <1% 372 $15K
83690 <1% 4,416 $14K
80061 Lipid panel <1% 1,126 $13K
73221 <1% 54 $12K
J1756 Injection, iron sucrose, 1 mg <1% 1,963 $12K
83880 <1% 546 $12K
84443 Thyroid stimulating hormone (TSH) <1% 657 $11K
71046 Radiologic examination, chest; 2 views <1% 1,084 $11K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 444 $11K
81025 <1% 4,078 $11K
80076 <1% 1,900 $11K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 147 $10K
J3490 Unclassified drugs <1% 2,549 $9K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,823 $9K
81001 <1% 4,639 $9K
93971 <1% 171 $9K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 604 $9K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 600 $8K
96361 Intravenous infusion, hydration; each additional hour <1% 778 $8K
87040 <1% 778 $8K
84703 <1% 1,108 $7K
70486 <1% 143 $7K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 474 $7K
Q3014 Telehealth originating site facility fee <1% 464 $7K
J1815 Injection, insulin, per 5 units <1% 720 $7K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 268 $7K
83036 Hemoglobin; glycosylated (A1C) <1% 1,257 $6K
73630 <1% 724 $6K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 240 $6K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,596 $6K
73610 <1% 438 $6K
93017 <1% 235 $6K
86803 <1% 346 $5K
70551 Magnetic resonance imaging, brain; without contrast material <1% 28 $5K
62323 <1% 25 $5K
73564 <1% 355 $5K
81003 <1% 2,464 $5K
J7030 Infusion, normal saline solution , 1000 cc <1% 13,001 $5K
73030 <1% 368 $4K
72100 <1% 280 $4K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 56 $4K
84100 <1% 977 $4K
96523 <1% 288 $4K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 117 $4K
73130 <1% 432 $3K
90715 <1% 699 $3K
84702 <1% 268 $3K
72141 <1% 16 $3K
82565 <1% 828 $3K
84153 <1% 166 $3K
85379 <1% 446 $3K
73562 <1% 218 $3K
96415 <1% 154 $3K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 315 $3K
82607 <1% 307 $3K
82728 <1% 338 $3K
73502 <1% 207 $3K
85027 <1% 690 $3K
80051 <1% 644 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 577 $3K
80329 <1% 230 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 69 $2K
80305 <1% 362 $2K
82550 <1% 398 $2K
73110 <1% 262 $2K
84520 <1% 648 $2K
J3535 Drug administered through a metered dose inhaler <1% 519 $2K
83540 <1% 314 $2K
76536 <1% 42 $2K
82962 <1% 1,371 $2K
70496 <1% 12 $2K
87186 <1% 276 $2K
86850 <1% 347 $2K
87340 <1% 141 $2K
93970 <1% 31 $2K
87905 <1% 180 $2K
82746 <1% 183 $2K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 45 $1K
87808 <1% 187 $1K
J1170 Injection, hydromorphone, up to 4 mg <1% 3,993 $1K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 338 $1K
82043 <1% 228 $1K
84439 <1% 195 $1K
94644 <1% 91 $1K
82947 <1% 646 $1K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 26 $1K
87077 <1% 245 $1K
82010 <1% 344 $1K
74018 <1% 162 $1K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 64 $1K
94729 <1% 55 $1K
J2469 Injection, palonosetron hcl, 25 mcg <1% 148 $1K
83550 <1% 302 $1K
85651 <1% 462 $1K
76770 <1% 34 $973.10
87070 <1% 259 $951.44
88342 <1% 46 $941.32
87081 <1% 312 $925.12
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 322 $920.10
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,936 $908.55
94726 <1% 42 $907.41
82977 <1% 121 $859.56
86901 <1% 359 $840.98
93922 <1% 34 $835.53
86900 <1% 360 $834.68
93925 <1% 13 $770.56
87205 <1% 260 $615.56
86140 <1% 242 $560.81
86592 <1% 145 $511.13
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 592 $506.71
94060 <1% 66 $502.96
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,341 $494.58
J0780 Injection, prochlorperazine, up to 10 mg <1% 981 $428.92
86706 <1% 41 $393.89
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,551 $364.80
73590 <1% 31 $349.15
J1644 Injection, heparin sodium, per 1000 units <1% 1,537 $303.19
97161 <1% 13 $279.88
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 200 $276.44
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,154 $265.42
97162 <1% 60 $259.72
73080 <1% 30 $238.70
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,745 $236.97
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,593 $227.46
80069 <1% 51 $217.03
96376 <1% 195 $213.33
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 184 $209.04
J3370 Injection, vancomycin hcl, 500 mg <1% 195 $206.22
J7060 5% dextrose/water (500 ml = 1 unit) <1% 922 $190.95
84550 <1% 30 $189.48
72050 <1% 13 $185.10
J7999 Compounded drug, not otherwise classified <1% 118 $184.00
J0690 Injection, cefazolin sodium, 500 mg <1% 293 $156.20
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,107 $141.07
J1650 Injection, enoxaparin sodium, 10 mg <1% 673 $123.69
J2270 Injection, morphine sulfate, up to 10 mg <1% 166 $123.63
J1626 Injection, granisetron hydrochloride, 100 mcg <1% 91 $111.75
J2060 Injection, lorazepam, 2 mg <1% 1,008 $95.92
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 708 $94.05
J7050 Infusion, normal saline solution, 250 cc <1% 1,359 $84.89
J3475 Injection, magnesium sulfate, per 500 mg <1% 624 $71.79
82570 <1% 18 $70.83
J3480 Injection, potassium chloride, per 2 meq <1% 213 $66.79
85018 <1% 30 $60.35
J1040 Injection, methylprednisolone acetate, 80 mg <1% 14 $57.69
83615 <1% 15 $56.82
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 928 $51.42
82140 <1% 13 $38.50
82150 <1% 12 $38.00
36415 Collection of venous blood by venipuncture <1% 3,157 $32.18
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 2,207 $28.35
94760 <1% 126 $25.29
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,374 $24.26
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge <1% 538 $23.33
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 152 $20.10
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 55 $17.36
J2704 Injection, propofol, 10 mg <1% 308 $17.02
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 19 $16.56
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 165 $8.94
36591 <1% 261 $7.70
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 435 $3.90
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg 0% 110 $0.00
J0692 Injection, cefepime hydrochloride, 500 mg 0% 35 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 135 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 98 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 0% 13 $0.00
J1953 Injection, levetiracetam, 10 mg 0% 27 $0.00
J7510 Prednisolone oral, per 5 mg 0% 12 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 1,136 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 53 $0.00
J3411 Injection, thiamine hcl, 100 mg 0% 14 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 13 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 35 $0.00
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml 0% 25 $0.00
97166 0% 13 $0.00
S0020 Injection, bupivicaine hydrochloride, 30 ml 0% 31 $0.00
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 0% 24 $0.00
J2360 Injection, orphenadrine citrate, up to 60 mg 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTIMMONS, LAURENE (CFO)
Same official

Other billing entities under TIMMONS, LAURENE

Full network →
ProviderLocationPaid
Upmc EastMonroeville, PA$5.77M
Upmc MckeesportMckeesport, PA$34.43

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.